Sunday, October 18, 2020

Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials: Centre

Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health...

from NDTV News - Topstories https://ift.tt/3lXILh9
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US Cybersecurity Agency Uses Anthropic AI Model To Audit Government Software

CISA is using Anthropic's Mythos AI to scan government code repositories for security bugs, uncovering many vulnerabilities amid ongoing...